Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study F. Valenzuela, C. de la Cruz Fernandez, R.L. Galimberti, S. Gürbüz, M. McKean-Matthews, L. Goncalves, R. Romiti

Evaluation of the Risk of Psoriatic Arthritis in Patients With Psoriasis Undergoing Biological Treatment. Global Population Study (TRINETX) R. Rivera-Diaz, B. Joven, G. Hernandez-Ibarburu, C. García-Donoso, J.L. Pablos, P.L. Ortiz-Romero

Nail psoriasis as a predictor of the development of psoriatic arthritis I. Raposo, T. Torres